DRUG · Mapped RxNorm record
Letrozole
Normalized identity: letrozoleView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men
NCT02097680
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedInfluence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Obesityverified · MONDO: obesity disorder
Interventions
LetrozoleDRUG · verified · RxNorm: letrozole
PlaceboDRUG
Sponsors & collaborators
University Hospital, Ghentlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02097680 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.